Diltiazem
Active ingredient · 2 therapeutic classes
Sold as ANGITIL SR 90 · ANGITIL XL 300 · ANGITIL SR 120 · ANGITIL SR 180 · ANGITIL XL 240
- Drug class
- Muscle Relaxants
- Availability
- Prescription only
- Routes
- Oral, Intravenous
- Markets covered
- 3
- Products on record
- 123
Overview
Diltiazem is an active pharmaceutical ingredient in the Muscle Relaxants group (C05AE). The information below is compiled per regulator from the product labels on record, with direct links to the original documents.
Regulatory status by market
| Market | Regulator | Products | Last revision |
|---|---|---|---|
| GB United Kingdom | MHRA | 95 | May 29, 2026 |
| CA Canada | Health Canada | 18 | March 17, 2026 |
| US United States | FDA | 10 | April 29, 2026 |
GBUnited Kingdom· MHRA
95 products
Uses
The prophylaxis of angina pectoris. The treatment of mild to moderate hypertension.
How to take
CACanada· Health Canada
18 products
Uses
DILTIAZEM CD (Diltiazem Hydrochloride Controlled Delivery Capsules) is indicated for: • Angina DILTIAZEM CD is indicated for the management of chronic stable angina (effort- associated angina) without evidence of vasospasm in patients who remain symptomatic, despite adequate doses of beta-blockers and/or organic nitrates or who cannot tolerate those agents.
DILTIAZEM CD may be tried in combination with beta-blockers in chronic stable angina patients with normal ventricular function. When such concomitant therapy is introduced, patients must be monitored closely (see 7 WARNINGS AND PRECAUTIONS).
• Hypertension DILTIAZEM CD is indicated for the treatment of mild to moderate essential hypertension. Safety of concurrent use of diltiazem with other antihypertensive agents has not been established. 1 Pediatrics Pediatrics (< 18 years): Based on the data submitted and reviewed by Health Canada, the safety and efficacy of DILTIAZEM CD in pediatric patients has not been established; therefore, Health Canada has not authorized an indication for pediatric use.
USUnited States· FDA
10 products
Uses
INDICATIONS AND USAGE
Diltiazem hydrochloride extended-release capsules are indicated for the treatment of hypertension. It may be used alone or in combination with other antihypertensive medications. Diltiazem hydrochloride extended-release capsules are indicated for the management of chronic stable angina and angina due to coronary artery spasm.
How to take
Drug interactions
Known interactions involving Diltiazem. Select one for details. This list is informational and not a complete interaction checker.
Showing 240 of 600. Type above to find a specific drug.
Interaction data compiled from DDInter (academic, CC-BY). Severity classification only - this is not a complete interaction checker and not medical advice.
Sources & citations
- [1]MHRA (UK) · PL284440204 · revised October 3, 2025
- [2]Health Canada (DPD) · 02400421 · revised March 22, 2025
- [3]FDA DailyMed · 0089fc7a-a7aa-48… · revised August 20, 2025 [PDF]
Information on this page is compiled from public regulatory records. Drugvu is not affiliated with any regulator or pharmaceutical manufacturer. This is not medical advice. Always consult a qualified healthcare professional.